Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|51||2013||Chairman of the Board, President|
|52||2013||Vice Chairman of the Board|
|44||2010||Chief Financial Officer, Finance Director, Vice President|
|54||2007||Vice President, Secretary of the Board|
|45||2011||Vice President, Director|
- BRIEF-Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial
- BRIEF-Zhejiang Conba Pharma's 9-month net profit down 26.8 pct
- BRIEF-Zhejiang Conba Pharmaceutical issues 1.1 bln yuan 5-YR bonds
- BRIEF-Zhejiang Conba Pharmaceutical to issue 1.1 bln yuan 5-yr bonds
- BRIEF-Zhejiang Conba Pharmaceutical unit gets clinical trial approval for Anidulafungin Anidulafungin for injection